Search | IOVS | ARVO Journals

Showing 1 – 20 of 60

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Intravitreal Propanolol for Proliferative Diabetic Retinopathy: Prelimiary results from a Phase-I Clinical Trial

Francyne Veiga Cyrino; Renata Moreto; Annelise Goncalves; Tomas Teixeira Pinto; André Vieira Messias; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):302.

ARVO Annual Meeting Abstract June 2020

Functional and structural changes in treated ocular syphilis

Renata Moreto; Andre Messias; Milena Simões; Annelise Goncalves; Leandro Jerez Chaves; Rodrigo Jorge; Justine R Smith; Joao M Furtado

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5378.

ARVO Annual Meeting Abstract June 2020

Scleral fixation using a hydrophilic four-haptic lens and polytetrafluoroethylene suture: phase I clinical trial

Natacha Bíscaro Junqueira; Leandro Jerez Chaves; Omero Benedicto Poli-Neto; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1663.

ARVO Annual Meeting Abstract June 2020

Mathematical models using OCT parameters to predict macular hole closure rates: a post-hoc analysis from a prospective clinical trial

Rodrigo Jorge; Tomas Teixeira Pinto; Karlos Italo Viana; Andre Messias

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4396.

ARVO Annual Meeting Abstract June 2020

Randomized Controlled Trial Comparing the Effects on Eye Pressure of Intravitreal Triamcinolone Injection versus Intravitreal Dexamethasone (Ozurdex) Implant in Patients with Diabetic Macular Edema TRIDEX TRIAL

Enzo Augusto Medeiros Fulco; Natacha Bíscaro Junqueira; Andre Messias; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):289.

ARVO Annual Meeting Abstract July 2019

The Light-adapted Full-field ERG Luminance-response Series in Proliferative Diabetic Retinopathy Treated with Intravitreal Ranibizumab and Multispot Laser Panretinal Photocoagulation

Andre Messias; Messias Katharina; Rafael de Montier Barroso; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5954.

ARVO Annual Meeting Abstract July 2019

Decreased retinal sensitivity overlying melanocytic choroidal lesions evaluated by microperimetry

Rodrigo Jorge; Marina Labarrere; Andre Messias; Zelia Correa

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):726.

ARVO Annual Meeting Abstract July 2019

Frequency of anti- Toxoplasma gondii serology, ocular lesions and associated risk factors in Cássia dos Coqueiros, Brazil.

Joao M Furtado; Rafael De Angelis; Jayter de Paula; Valdes Bollela; Milena Simões; Bárbara Vieira; Moises Lucena; Thais Moralles; Rodrigo Jorge; Afonso Costa Passos; Maria de Lourdes Rodrigues

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6677.

ARVO Annual Meeting Abstract June 2017

Standardization of retinal thickness and volume on ETDRS grid subdivisions using SD-OCT

Renato Peroni; Rafael Memória; Bruno Nascimento; Lucélia Albieri; Murilo Wendeborn Rodrigues; José Augusto Cardillo; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1320.

ARVO Annual Meeting Abstract June 2017

Bevacizumab or Triamcinolone for Persistent Diabetic Macular Edema: 24-week preliminary results

Murilo Wendeborn Rodrigues; Andre Messias; Jose Augusto Cardillo; Rubens C Siqueira; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):954.

ARVO Annual Meeting Abstract June 2017

Combined Pars Plana Vitrectomy (PPV) and Phacoemulsification (Phaco) versus PPV and Deferred Phaco for Patients with Macular Hole (MH) or Epiretinal Membrane (ERM)

Rodrigo Jorge; Karlos Italo Viana; David Lucena; Marcelo Menegatti Esperandio; Denny Marcos Garcia; Felipe Piacentini Almeida; Andre Messias; Ingrid U Scott

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2805.

ARVO Annual Meeting Abstract June 2017

The Influence of Dark and Light Adaptation on Phosphene Thresholds Elicited with DTL Electrodes

renan rocha memória; Santana José Galdino Souza; Rodrigo Jorge; Andre Messias

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5879.

ARVO Annual Meeting Abstract September 2016

Reduced photoreceptor density over Choroid Nevus

Murilo Wendeborn Rodrigues; Jose A Cardillo; Emil Say; Felipe Borges; Rubens C Siqueira; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5099.

ARVO Annual Meeting Abstract September 2016

Adaptive optics and its correlation with multimodal imaging and microperimetry in patients with macular capillary loss

Rodrigo Jorge; Felipe Placeres Borges; Murilo Wendeborn Rodrigues; Ingrid U Scott; Rubens C Siqueira

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6317.

ARVO Annual Meeting Abstract September 2016

Intravitreal Autologous Bone Marrow Derived Stem Cells in Dry Age-related Macular Degeneration

Rubens C Siqueira; Carina Costa Cotrim; Andre Messias; Monique Viana de Sousa; Luiza Toscano; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3704.

ARVO Annual Meeting Abstract September 2016

Intravitreal Autologous Bone Marrow Derived Stem Cells in Ischemic Maculopathy Results after 12 Months Follow-up

Felipe Placeres Borges; Rubens C Siqueira; Murilo Wendeborn Rodrigues; Amanda Jardim Dos Santos; Andre Messias; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3741.

ARVO Annual Meeting Abstract June 2015

PASCAL panretinal photocoagulation (PRP) versus ETDRS PRP associated with intravitreal Ranibizumab (IVR) versus only IVR for proliferative diabetic retinopathy treatment

Rafael de Montier Barroso; Andre Messias; Jose A Cardillo; Rodrigo Jorge; Ophthalmology Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1773.

ARVO Annual Meeting Abstract June 2015

Full-field Stimulus Threshold (FST) Changes After Intravitreal Ranibizumab and Single or Multiple Spot Panphotocoagulation in Proliferative Diabetic Retinopathy

Andre Messias; Katharina Messias; Rafael de Montier Barroso; Amanda Marega; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1776.

ARVO Annual Meeting Abstract June 2015

Reduced-Dose Indocyanine Green Photodynamic Therapy (iPDT) as an Optimized Treatment for Chronic Central Serous Chorioretinopathy

Jose A Cardillo; Leticia Barroso; Murilo Wendeborn Rodrigues; Rodrigo Jorge; Acacio Lima

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):201.

ARVO Annual Meeting Abstract June 2015

ERG Findings after One Year Intravitreal Ranibizumab and Single or Multiple Spot Panphotocoagulation Treatment for Proliferative Diabetic Retinopathy

Katharina Messias; Rafael de Montier Barroso; Fabiano Sakamoto; Vinicius Monteiro de Castro; Amanda Marega; Rodrigo Jorge; Andre Messias

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):764.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Intravitreal Propanolol for Proliferative Diabetic Retinopathy: Prelimiary results from a Phase-I Clinical Trial

Functional and structural changes in treated ocular syphilis

Scleral fixation using a hydrophilic four-haptic lens and polytetrafluoroethylene suture: phase I clinical trial

Mathematical models using OCT parameters to predict macular hole closure rates: a post-hoc analysis from a prospective clinical trial

Randomized Controlled Trial Comparing the Effects on Eye Pressure of Intravitreal Triamcinolone Injection versus Intravitreal Dexamethasone (Ozurdex) Implant in Patients with Diabetic Macular Edema TRIDEX TRIAL

The Light-adapted Full-field ERG Luminance-response Series in Proliferative Diabetic Retinopathy Treated with Intravitreal Ranibizumab and Multispot Laser Panretinal Photocoagulation

Decreased retinal sensitivity overlying melanocytic choroidal lesions evaluated by microperimetry

Frequency of anti- Toxoplasma gondii serology, ocular lesions and associated risk factors in Cássia dos Coqueiros, Brazil.

Standardization of retinal thickness and volume on ETDRS grid subdivisions using SD-OCT

Bevacizumab or Triamcinolone for Persistent Diabetic Macular Edema: 24-week preliminary results

Combined Pars Plana Vitrectomy (PPV) and Phacoemulsification (Phaco) versus PPV and Deferred Phaco for Patients with Macular Hole (MH) or Epiretinal Membrane (ERM)

The Influence of Dark and Light Adaptation on Phosphene Thresholds Elicited with DTL Electrodes

Reduced photoreceptor density over Choroid Nevus

Adaptive optics and its correlation with multimodal imaging and microperimetry in patients with macular capillary loss

Intravitreal Autologous Bone Marrow Derived Stem Cells in Dry Age-related Macular Degeneration

Intravitreal Autologous Bone Marrow Derived Stem Cells in Ischemic Maculopathy Results after 12 Months Follow-up

PASCAL panretinal photocoagulation (PRP) versus ETDRS PRP associated with intravitreal Ranibizumab (IVR) versus only IVR for proliferative diabetic retinopathy treatment

Full-field Stimulus Threshold (FST) Changes After Intravitreal Ranibizumab and Single or Multiple Spot Panphotocoagulation in Proliferative Diabetic Retinopathy

Reduced-Dose Indocyanine Green Photodynamic Therapy (iPDT) as an Optimized Treatment for Chronic Central Serous Chorioretinopathy

ERG Findings after One Year Intravitreal Ranibizumab and Single or Multiple Spot Panphotocoagulation Treatment for Proliferative Diabetic Retinopathy

To View More...

You must be signed into an individual account to use this feature.